CD4 and amyloidosis: By using a GLM with sex and age as covariates on T cell subsets, we found that CD8+ effector T cells and CD57+ KLRG1+ CD4+ terminally differentiated effector memory T cells were higher in MCI patients with amyloid pathology (Fig. 1j).